Influence of Non-Toxic Doses of Bevacizumab and Ranibizumab on Endothelial Functions and Inhibition of Angiogenesis

Author： Barzelay Aya   Lowenstein Anat   George Jacob   Barak Adiel  

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.35, Iss.9, 2010-09, pp. : 835-841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Ranibizumab and Bevacizumab: A Review of Risk

By Dafer Rima   Schneck Michael   Friberg Thomas   Jay Walter  

Seminars in Ophthalmology, Vol. 22, Iss. 3, 2007-07 ,pp. : 201-204

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis: Trabeculectomy and Bevacizumab

By Jue Andrea  

Seminars in Ophthalmology, Vol. 24, Iss. 2, 2009-03 ,pp. : 122-125

Informa Healthcare

Access to resources Recommend Favorite

Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile

By  

Ophthalmologica, Vol. 234, Iss. 4, 2015-0 ,pp. : 195-210

Karger

Access to resources Recommend Favorite

Inhibition of Ocular Angiogenesis by Diced Small Interfering RNAs (siRNAs) Specific to Vascular Endothelial Growth Factor (VEGF)

By Murata Masatoshi   Takanami Takako   Shimizu Shinji   Kubota Yosiko   Horiuchi Saburo   Habano Wataru   Ma Jian-xing   Sato Sanai  

Current Eye Research, Vol. 31, Iss. 2, 2006-02 ,pp. : 171-180

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab

By Kanoff Justin   Miller Joan  

Seminars in Ophthalmology, Vol. 28, Iss. 5-6, 2013-09 ,pp. : 355-360

Informa Healthcare

Access to resources Recommend Favorite